Language Select
Logótipo Varian

Notícias recentes

Junho 17, 2019
Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes during the closing period to the original... Read more
Junho 13, 2019
Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI), federated data sources and clinical decision support at the 19th International... Read more
Junho 12, 2019
Varian (NYSE: VAR) today announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the FlashForward™ Consortium. The Consortium... Read more

Publicações recentes do blogue

Jun 20, 2019 | Centerline
After 20 years with one oncology information system (OIS), migrating to an entirely new one is a serious step, but it’s one that Baton Rouge General took in the summer of 2016 with an eye to the... Read more
Jun 10, 2019 | Centerline
Varian has acquired Endocare, based in Austin, Texas; and Alicon, based in Hangzhou, China. Endocare is a leading provider of technology for cryoablation and microwave ablation. In China, Alicon is... Read more
Jun 04, 2019 | Centerline
Varian’s RapidPlan™ knowledge-based planning brings the power of machine learning to the challenge of treatment planning and has been helping clinicians at centers around the world since 2014 to... Read more

Receber notícias por e-mail
Assinar agora

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com